Delivery Order SPE2DB20D3303-SPE2DB25FA2VW
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. The contract has a ceiling value of $5,495.86 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025. The place of performance is the company's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a $7,085.19 delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a ceiling value of $1,135.11. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a small-value transaction within the pharmaceutical supply chain. The award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $41,346.30 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued with no set-aside designation, reflecting the open competition process...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,616.16 by the Defense Logistics Agency on September 16, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 17, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $4,167.89 for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitively awarded transaction under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,701.45 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- On July 22, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2VWDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. The contract, valued at $7,567.40, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026. The delivery order supports DLA's Medical Supply Chain, which procures critical pharmaceutical products for military and veteran healthcare systems. Repatha, a cholesterol-lowering medication, represents one of many specialty and brand-name pharmaceuticals that AmerisourceBergen supplies through its federal contract portfolio. As a major pharmaceutical distributor, AmerisourceBergen serves as a prime vendor for the Defense Health Agency and other federal healthcare customers, providing medications across multiple therapeutic domains including specialty treatments, vaccines, and medical devices. The competitive award reflects the company's established capability to meet federal procurement requirements and supply critical medical commodities to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/21/25 |